Hutch News
Results per Page:
Is the microbiome a springboard or barrier to effective vaccination?
From the Kublin Lab, Vaccine and Infectious Disease Division
Could a 100-year-old TB vaccine help scientists find a better one?
Harmless vaccine BCG is made of living bacteria; in tests might serve as a proxy for deadly tuberculosis
AIDS@40: Stories of hope and heroes
The people and the science devoted to stopping HIV
Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’
Summaries of recent Fred Hutch research findings and other news
Biostatisticians draft blueprints for COVID-19 vax trials
Hutch group applies skills honed during decades of HIV prevention trials to bring about safe and effective vaccines for a new pandemic
Scientists ponder human challenge trials for COVID-19 vaccines
Thousands offer to be infected with live virus to speed vaccine development
Study points toward progress on TB vaccines
High-tech analysis of correlates of protection may improve 100-year-old vaccine strategy
Improving HIV clinical trials with mobile technology
From the HIV Vaccine Trials Network, Vaccine and Infectious Disease Division
Enlisting the microbiome in the quest for an AIDS vaccine
We now know that microbial communities, especially in our guts, profoundly affect immune response
On the path to a new-generation malaria vaccine
New approach using genetically modified parasite ‘primes the immune system’ in first human trial
'Roz and Ray': An HIV tragedy with lessons for today
Seattle Repertory drama, panel explore fallout from an early AIDS crisis in hemophiliacs
Good News: Dr. David Maloney named cellular immunotherapy medical director at Fred Hutch, SCCA; Dr. Jim Kublin gets grant to study how gut bugs alter HIV vaccine response
Celebrating faculty and staff achievements
First test of 'off-the-shelf' cord blood cell product outside the transplantation setting
Celebrating faculty and staff achievements
Getting malaria on purpose
Volunteers roll up their sleeves and get infected to test an experimental drug
Zika virus: 6 key things we don’t yet know
From lack of data to inconclusive blood tests to the unique challenges of pregnancy, experts weigh in on the knowledge gaps in this emerging infection
Charlie Sheen’s announcement reveals ‘ugly ogre underneath’ public awareness of HIV
Reactions underscore disease’s lingering stigma
Fantastic failures: Scientific setbacks fuel big gains
Whether solving the mysteries of outer space or cancer cells, many major advances followed messy moments
Gut microbiome may have interfered with experimental HIV vaccines
Inoculating infants instead of adults could bypass problem, researchers say
Finding a better way to take a bite out of malaria’s power
Fred Hutch and collaborators launch new trials to infect – and quickly treat – volunteers to test experimental drugs
Fred Hutchinson Cancer Research Center and Seattle BioMed team up on malaria clinical trials
Studies to test drugs that may be useful for malaria treatment and prevention